Terms: = Breast cancer AND NCOA1, RIP160, 8648, ENSG00000084676, NCoA-1, SRC1, MGC129719, MGC129720, F-SRC-1 AND Treatment
51 results:
1. Steroid receptor coactivator 1 promotes human hepatocellular carcinoma invasiveness through enhancing MMP-9.
Tong Z; Zhang Y; Guo P; Wang W; Chen Q; Jin J; Liu S; Yu C; Mo P; Zhang L; Huang J
J Cell Mol Med; 2024 Apr; 28(7):e18171. PubMed ID: 38506084
[TBL] [Abstract] [Full Text] [Related]
2. Molecular characterization of circulating tumour cells identifies predictive markers for outcome in primary, triple-negative breast cancer patients.
Bittner AK; Keup C; Hoffmann O; Hauch S; Kimmig R; Kasimir-Bauer S
J Cell Mol Med; 2020 Aug; 24(15):8405-8416. PubMed ID: 32558176
[TBL] [Abstract] [Full Text] [Related]
3. Steroid receptor coactivator-1 regulates glioma angiogenesis through polyomavirus enhancer activator 3 signaling.
Zhang Y; Shi W
Biochem Cell Biol; 2019 Aug; 97(4):488-496. PubMed ID: 30532986
[TBL] [Abstract] [Full Text] [Related]
4. The oncogenic roles of nuclear receptor coactivator 1 in human esophageal carcinoma.
Wang L; Li W; Li K; Guo Y; Liu D; Yao Z; Lin X; Li S; Jiang Z; Liu Q; Jiang Y; Zhang B; Chen L; Zhou F; Ren H; Lin D; Zhang D; Yeung SJ; Zhang H
Cancer Med; 2018 Oct; 7(10):5205-5216. PubMed ID: 30270520
[TBL] [Abstract] [Full Text] [Related]
5. Oestrogenic activity of mimosine on MCF-7 breast cancer cell line through the ERα-mediated pathway.
Huq AM; Wai LK; Rullah K; Mohd Aluwi MFF; Stanslas J; Jamal JA
Chem Biol Drug Des; 2019 Mar; 93(3):222-231. PubMed ID: 30251480
[TBL] [Abstract] [Full Text] [Related]
6. Loss of Estrogen-Regulated
Zhang W; Wu M; Chong QY; Zhang M; Zhang X; Hu L; Zhong Y; Qian P; Kong X; Tan S; Li G; Ding K; Lobie PE; Zhu T
Cancer Res; 2018 Sep; 78(17):4915-4928. PubMed ID: 29945962
[TBL] [Abstract] [Full Text] [Related]
7. Epigenome-wide SRC-1-Mediated Gene Silencing Represses Cellular Differentiation in Advanced breast cancer.
Ward E; Varešlija D; Charmsaz S; Fagan A; Browne AL; Cosgrove N; Cocchiglia S; Purcell SP; Hudson L; Das S; O'Connor D; O'Halloran PJ; Sims AH; Hill AD; Young LS
Clin Cancer Res; 2018 Aug; 24(15):3692-3703. PubMed ID: 29567811
[No Abstract] [Full Text] [Related]
8. Melatonin inhibits the proliferation of breast cancer cells induced by bisphenol A via targeting estrogen receptor-related pathways.
Wang T; Liu B; Guan Y; Gong M; Zhang W; Pan J; Liu Y; Liang R; Yuan Y; Ye L
Thorac Cancer; 2018 Mar; 9(3):368-375. PubMed ID: 29330934
[TBL] [Abstract] [Full Text] [Related]
9. Implications of a peroxisome proliferator-activated receptor alpha (PPARα) ligand clofibrate in breast cancer.
Chandran K; Goswami S; Sharma-Walia N
Oncotarget; 2016 Mar; 7(13):15577-99. PubMed ID: 26621841
[TBL] [Abstract] [Full Text] [Related]
10. ncoa1 promotes angiogenesis in breast tumors by simultaneously enhancing both HIF1α- and AP-1-mediated VEGFa transcription.
Qin L; Xu Y; Xu Y; Ma G; Liao L; Wu Y; Li Y; Wang X; Wang X; Jiang J; Wang J; Xu J
Oncotarget; 2015 Sep; 6(27):23890-904. PubMed ID: 26287601
[TBL] [Abstract] [Full Text] [Related]
11. Modification of ASC1 by UFM1 is crucial for ERα transactivation and breast cancer development.
Yoo HM; Kang SH; Kim JY; Lee JE; Seong MW; Lee SW; Ka SH; Sou YS; Komatsu M; Tanaka K; Lee ST; Noh DY; Baek SH; Jeon YJ; Chung CH
Mol Cell; 2014 Oct; 56(2):261-274. PubMed ID: 25219498
[TBL] [Abstract] [Full Text] [Related]
12. A novel functional interplay between Progesterone Receptor-B and PTEN, via AKT, modulates autophagy in breast cancer cells.
De Amicis F; Guido C; Santoro M; Lanzino M; Panza S; Avena P; Panno ML; Perrotta I; Aquila S; Andò S
J Cell Mol Med; 2014 Nov; 18(11):2252-65. PubMed ID: 25216078
[TBL] [Abstract] [Full Text] [Related]
13. Evaluation of the ability of adjuvant tamoxifen-benefit gene signatures to predict outcome of hormone-naive estrogen receptor-positive breast cancer patients treated with tamoxifen in the advanced setting.
Sieuwerts AM; Lyng MB; Meijer-van Gelder ME; de Weerd V; Sweep FC; Foekens JA; Span PN; Martens JW; Ditzel HJ
Mol Oncol; 2014 Dec; 8(8):1679-89. PubMed ID: 25081647
[TBL] [Abstract] [Full Text] [Related]
14. LXXLL peptide converts transportan 10 to a potent inducer of apoptosis in breast cancer cells.
Tints K; Prink M; Neuman T; Palm K
Int J Mol Sci; 2014 Apr; 15(4):5680-98. PubMed ID: 24705462
[TBL] [Abstract] [Full Text] [Related]
15. NCOA3 is a selective co-activator of estrogen receptor α-mediated transactivation of PLAC1 in MCF-7 breast cancer cells.
Wagner M; Koslowski M; Paret C; Schmidt M; Türeci O; Sahin U
BMC Cancer; 2013 Dec; 13():570. PubMed ID: 24304549
[TBL] [Abstract] [Full Text] [Related]
16. Steroid receptor coactivator-3 promotes bladder cancer through upregulation of CXCR4.
Zhang Y; Wang JH; Liu B; Qu PB
Asian Pac J Cancer Prev; 2013; 14(6):3847-50. PubMed ID: 23886194
[TBL] [Abstract] [Full Text] [Related]
17. ADAM22 as a prognostic and therapeutic drug target in the treatment of endocrine-resistant breast cancer.
Bolger JC; Young LS
Vitam Horm; 2013; 93():307-21. PubMed ID: 23810013
[TBL] [Abstract] [Full Text] [Related]
18. cancer in Kashmir, India: burden and pattern of disease.
Rasool MT; Lone MM; Wani ML; Afroz F; Zaffar S; Mohib-ul Haq M
J Cancer Res Ther; 2012; 8(2):243-6. PubMed ID: 22842369
[TBL] [Abstract] [Full Text] [Related]
19. Inhibition of p38-MAPK alters SRC coactivation and estrogen receptor phosphorylation.
Antoon JW; Bratton MR; Guillot LM; Wadsworth S; Salvo VA; Burow ME
Cancer Biol Ther; 2012 Sep; 13(11):1026-33. PubMed ID: 22825349
[TBL] [Abstract] [Full Text] [Related]
20. Steroid receptor coactivators, HER-2 and HER-3 expression is stimulated by tamoxifen treatment in DMBA-induced breast cancer.
Moi LL; Flågeng MH; Gjerde J; Madsen A; Røst TH; Gudbrandsen OA; Lien EA; Mellgren G
BMC Cancer; 2012 Jun; 12():247. PubMed ID: 22703232
[TBL] [Abstract] [Full Text] [Related]
[Next]